This is a $1,866,116.00 delivery order task order awarded to Mriglobal, doing business as Midwest Research Institute, a 501(c)(3) not-for-profit research organization. The task order was awarded by the National Cancer Institute, a civilian agency, for (1) production of a drug substance, (2) conversion of drug substance to drug product, (3) filling drug product into applicators for clinical trials, and (4) production of a placebo product. The work is to be performed in Kansas City, Missouri, and has an ultimate completion date of September 17, 2026. There was no set-aside designation for this award. Mriglobal is a prime contractor that specializes in areas such as medical countermeasure development, biosafety testing, and pharmaceutical manufacturing. The company has received numerous prime federal contract awards and grants from agencies like the Department of Health and Human Services, Department of Defense, and Department of Homeland Security to support a wide range of scientific research and testing services.
Generated 9/18/24, 9:46 AM